Last updated: 4 September 2024 at 4:15pm EST

James G. Chopas CPA Net Worth




The estimated Net Worth of James George Chopas is at least $1.67 Million dollars as of 3 September 2024. Mr Chopas owns over 550 units of Apellis Pharmaceuticals Inc stock worth over $1,470,454 and over the last 4 years he sold APLS stock worth over $195,318.

Mr CPA APLS stock SEC Form 4 insiders trading

Mr has made over 7 trades of the Apellis Pharmaceuticals Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 550 units of APLS stock worth $21,720 on 3 September 2024.

The largest trade he's ever made was selling 1,061 units of Apellis Pharmaceuticals Inc stock on 22 January 2024 worth over $68,965. On average, Mr trades about 206 units every 71 days since 2021. As of 3 September 2024 he still owns at least 38,333 units of Apellis Pharmaceuticals Inc stock.

You can see the complete history of Mr Chopas stock trades at the bottom of the page.





Mr. James G. Chopas CPA biography

James G. Chopas CPA is the VP, Corp. Controller & Chief Accounting Officer at Apellis Pharmaceuticals Inc.



How old is Mr CPA?

Mr CPA is 55, he's been the VP and Corp. Controller & Chief Accounting Officer of Apellis Pharmaceuticals Inc since . There are 3 older and 19 younger executives at Apellis Pharmaceuticals Inc. The oldest executive at Apellis Pharmaceuticals Inc is Gerald Chan, 69, who is the Independent Chairman of the Board.

What's Mr CPA's mailing address?

James's mailing address filed with the SEC is C/O APELLIS PHARMACEUTICALS, INC., 100 FIFTH AVENUE, 3RD FLOOR, WALTHAM, MA, 02451.

Insiders trading at Apellis Pharmaceuticals Inc

Over the last 6 years, insiders at Apellis Pharmaceuticals Inc have traded over $44,114,337 worth of Apellis Pharmaceuticals Inc stock and bought 1,248,415 units worth $38,006,599 . The most active insiders traders include Venture Investments Ltd Mor..., Cedric Francois, and Pascal Deschatelets. On average, Apellis Pharmaceuticals Inc executives and independent directors trade stock every 6 days with the average trade being worth of $665,393. The most recent stock trade was executed by James George Chopas on 3 September 2024, trading 550 units of APLS stock currently worth $21,720.



What does Apellis Pharmaceuticals Inc do?

apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.



What does Apellis Pharmaceuticals Inc's logo look like?

Apellis Pharmaceuticals Inc logo

Complete history of Mr Chopas stock trades at Radius Recycling and Apellis Pharmaceuticals Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
3 Sep 2024 James George Chopas
VP/Chief Accounting Officer
Sale 550 $39.49 $21,720
3 Sep 2024
38,333
15 Mar 2024 James George Chopas
VP/Chief Accounting Officer
Sale 184 $56.46 $10,389
15 Mar 2024
38,883
22 Jan 2024 James George Chopas
VP/Chief Accounting Officer
Sale 1,061 $65.00 $68,965
22 Jan 2024
39,067
16 Jan 2024 James George Chopas
VP/Chief Accounting Officer
Sale 864 $66.81 $57,724
16 Jan 2024
40,128
23 Oct 2023 James George Chopas
VP/Chief Accounting Officer
Sale 132 $46.04 $6,077
23 Oct 2023
32,680
31 Aug 2023 James George Chopas
VP/Chief Accounting Officer
Sale 551 $41.23 $22,718
31 Aug 2023
30,312
5 Mar 2021 James George Chopas
Principal Finance Accounting
Sale 370 $20.88 $7,726
5 Mar 2021
6,701


Apellis Pharmaceuticals Inc executives and stock owners

Apellis Pharmaceuticals Inc executives and other stock owners filed with the SEC include: